In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Health
F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson
August 26, 2026
1 min read
0 views
Share this article
Related Articles
Health1 day ago
Malaria, Likely Spread by Mosquito on Plane, Kills 2 Airport Workers in Germany
Claire Moses1 min
Health1 day ago
A $17.1 Billion Vote of Confidence That Jonathan Haidt Was Right
Emma Goldberg1 min
Health2 days ago
‘You’re Ruining My Dreams’: C.T.E. Study Adds to Family Tension Over Football
Juliet Macur1 min